Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. - Wikidata - awgldk - TriplyDB

Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.

Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.

http://www.wikidata.org/entity/Q39957382

about

Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation Biomarkers for stroke Novel methodologies for biomarker discovery in atherosclerosis Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Circulating endothelial microparticles involved in lung function decline in a rat exposed in cigarette smoke maybe from apoptotic pulmonary capillary endothelial cells Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.Endothelial microparticles: sophisticated vesicles modulating vascular function.Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort.Microvesicles derived from hypoxia/reoxygenation-treated human umbilical vein endothelial cells promote apoptosis and oxidative stress in H9c2 cardiomyocytes.An engineered ClyA nanopore detects folded target proteins by selective external association and pore entry The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome.Disturbed blood flow acutely induces activation and apoptosis of the human vascular endothelium.Time course of various cell origin circulating microparticles in ST-segment elevation myocardial infarction patients undergoing percutaneous transluminal coronary intervention.Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.Microparticles as novel biomarkers and therapeutic targets in coronary heart disease.Exploring the factors that affect blood cholesterol and heart disease risk: is dietary cholesterol as bad for you as history leads us to believe?Microvesicles: potential markers and mediators of endothelial dysfunction.Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?Annual FEV1 changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective study Procoagulant activity of circulating microparticles is associated with the presence of moderate calcified plaque burden detected by multislice computed tomography.Validation of the International Index of Erectile Function (IIFE) for use in Brazil.Microfluidic strategies applied to biomarker discovery and validation for multivariate diagnostics.Endothelial microparticles: missing link in endothelial dysfunction?Revisited role of microparticles in arterial and venous thrombosis.Microparticles in health and disease.The role of microparticles in chronic obstructive pulmonary disease The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease.Exosomes and Cardiovascular Protection.Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: Forward or side scatter?Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.Extracellular vesicles in coronary artery disease.Microparticles in sputum of COPD patients: a potential biomarker of the disease?Prognostic value of endothelial microparticles in patients with heart failure.Vascular Health Profile predicts cardiovascular outcomes in patients with diabetes.Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro.Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.

P2860

Q26865593-EDAD4B47-9FE9-45AF-B621-E8A1B87CBA0E Q27004404-FB06CAD7-0469-42BC-B029-03BFF273CB52 Q28088373-492FEBBA-0F50-4286-B49C-B13FF99369DC Q33776230-736AFBF0-2324-4AA3-A35E-02971D2C318A Q33814681-B13B5DF7-B1C6-418A-91EA-95CC202888EB Q34026858-4C15C48A-6412-4519-88B1-0182E4F53508 Q34488533-BCD130E3-5F17-4188-BB01-2FE654FA1103 Q35026270-328A1B18-A953-482D-B9DC-CE9388E88C1C Q35624092-06FADE9C-C5AE-4118-97D2-092BD5EADB25 Q35907034-B67742E2-F96F-436E-841A-792A99A9270A Q36060414-650BE089-75C8-4CDB-8D6C-D1EB02243076 Q36230061-3764A088-1891-4671-B638-3BEF98CE970D Q36399555-168C277F-178C-4281-8E09-9E7B786B41B2 Q36476672-E9D172DD-E8B1-4BBC-A35B-8612EA184ED7 Q36630135-98DCE248-1B1D-42CC-A9F5-5F2BACD2119B Q36741762-7E5AB166-4870-46E0-B3E1-C12232ADC0F0 Q36745194-4A187797-4264-47F9-9D33-A0AC17D7676A Q36816361-BD92E11A-533F-419D-BB0F-0F8B8F2A3D6A Q36828842-2E54E6AF-3030-43D7-859B-E010DD56F9DB Q37273154-BA0C8F80-B29F-404A-BCB5-ABB72408CC2B Q37295504-A300313E-79F4-442F-82F1-B1D2C062A7B3 Q37628496-F470D4CE-828A-4B72-8117-4DBD49465F2A Q37695163-6D68AEEE-06C8-4E5A-A862-440A1B34F353 Q37720731-AD45E871-AED8-462D-BFF8-BF7190F7F02E Q37943855-ACE6844A-590E-4680-91D7-C99E4B0CB0A6 Q38001993-8D44D9DD-9A07-4AEB-AD5E-C1D354E58D2E Q38117725-6A2E7F1F-4190-486C-B186-8389C3423851 Q38118341-B6691A35-D1D7-4630-ABD3-0334D81531F1 Q38202635-7F13448A-F7B8-400B-A969-9319D91CC2B5 Q38624868-104C8721-156C-4DBF-B026-CD0E9AE8616C Q38994668-5647C534-4BF3-4E54-889A-57DE6EA683A9 Q39008328-A2F8BED4-9DCD-4418-99BD-B5E45E29186D Q39095686-8186B105-8202-4EB0-9250-57581757B8D5 Q39115035-66F566DE-228A-4326-A1A5-A9E799DDA7D5 Q39167010-DA8C1079-7483-4C9D-B9CB-606B847CDB34 Q39840829-FD28D028-4D6F-4147-A613-BFDE30E72ABE Q40324178-10F87794-F9BA-43C0-B930-DF5EA964B30E Q42268357-01225538-34A8-41F3-B00D-199A53EB916D Q43472325-3BF58FA9-C7F0-42A5-9674-E970FB65A13F Q47964479-AD09B79C-C500-42D9-AD20-3AD40469FD6D

P2860

Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.

http://www.wikidata.org/entity/Q39957382

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Significance of a multiple bio ...... sk for coronary heart disease.

@en

Significance of a multiple bio ...... sk for coronary heart disease.

@nl

type

label

Significance of a multiple bio ...... sk for coronary heart disease.

@en

Significance of a multiple bio ...... sk for coronary heart disease.

@nl

prefLabel

Significance of a multiple bio ...... sk for coronary heart disease.

@en

Significance of a multiple bio ...... sk for coronary heart disease.

@nl

P1433

Q39957382-681DA6C7-0F17-42DC-87FF-38C8ABC8E32A

P1476

Q39957382-824A3BAC-0E21-474F-ADF4-11FD19C47DF3

P2093

Q39957382-24A16D5F-2826-404A-B433-BB736D5A5A68

Q39957382-2BA7D14F-BD53-47DE-B8F9-992852E04512

Q39957382-4BF73341-BFD1-4C8F-931F-0EFF15A44905

Q39957382-94FC4F19-F0AB-4815-8935-446A5EA4F848

Q39957382-A9874592-DFBE-4914-95E5-3F815D10406E

Q39957382-BDE501E1-8CA6-4D9C-887F-17D2A8AB09D6

Q39957382-D45F12CD-289A-4353-A32B-E2ABA2AC2C7C

Q39957382-E5017F56-D645-40F9-9814-20CA3A23E413

Q39957382-EB1A055F-9F76-4906-AFE7-72EA307C2C38

Q39957382-ED69C2EE-5B3D-4DF7-AF19-7ABF82FF8C8B

P304

Q39957382-9B54ABB1-BE61-485B-9D11-5E2CB539E4BC

P31

Q39957382-78B08E69-19B2-4825-A0E4-F1591D70FDF0

P356

Q39957382-34E135E0-22F2-47E3-8C0E-CCF9D4592C11

P407

Q39957382-01DD7703-35CD-41AB-BA27-DBB35B12F735

P433

Q39957382-B2331087-741E-4300-80AB-7774DF28F92A

P478

Q39957382-C210A0DB-E828-45C2-8DC4-CE25F49F82D4

P577

Q39957382-66EFBADE-C30E-4257-90C2-96C2FC4A02F2

P5875

Q39957382-3DD7FC13-1242-469A-9B72-39EEC7751F54

P698

Q39957382-18F368AB-F81C-493E-81E8-C385945261A8

P921

Q39957382-A6E9D129-C7B2-42B3-A181-0E89FAAE0BD4

Q39957382-C4F3E130-7E48-4965-9647-D8421DA07564

Q39957382-E4397179-05F4-48BE-A3A3-14ED6DC14660

Q39957382-FBA79A67-DFF0-451A-A425-B17760A17974

P356

J.JACC.2009.05.022

P1433

Journal of the American College of Cardiology

P1476

Significance of a multiple bio ...... sk for coronary heart disease.

@en

P2093

Hideaki Jinnouchi

http://www.w3.org/2001/XMLSchema#string

Hidenobu Koga

http://www.w3.org/2001/XMLSchema#string

Hisao Ogawa

http://www.w3.org/2001/XMLSchema#string

Hitoshi Sumida

http://www.w3.org/2001/XMLSchema#string

Keisuke Ohba

http://www.w3.org/2001/XMLSchema#string

Koichi Sugamura

http://www.w3.org/2001/XMLSchema#string

Kunihiko Matsui

http://www.w3.org/2001/XMLSchema#string

Seigo Sugiyama

http://www.w3.org/2001/XMLSchema#string

Toshimitsu Nozaki

http://www.w3.org/2001/XMLSchema#string

Yasushi Matsuzawa

http://www.w3.org/2001/XMLSchema#string

P304

601-608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2009.05.022

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26722719

http://www.w3.org/2001/XMLSchema#string

P698

19660689

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio